6
Participants
Start Date
July 31, 2008
Primary Completion Date
April 30, 2010
Study Completion Date
April 30, 2010
Axitinib (AG-013736)
Three single dose level of AG-013736 (5 mg, 7 mg and 10 mg) will be given for all patient. After single dosing at each dose level, multiple doses of 5 mg twice a day (BID) will be started.
Pfizer Investigational Site, Kobe
Lead Sponsor
Pfizer
INDUSTRY